Navigation Links
First demonstration of 'teaching' in non-human animals

Certain species of ant use a technique known as 'tandem running' to lead another ant from the nest to a food source. Signals between the two ants control both the speed and course of the run. It is believed to be the first time a demonstration of 'formal' teaching has been recognised in any non-human animal.

This behaviour indicates that it could be the value of information, rather than the constraint of brain size, that has influenced the evolution of teaching.

The research, by Professor Nigel Franks and Tom Richardson from Bristol University, is reported today in Nature [12 January 2006].

According to the accepted definition of teaching in animal behaviour, an individual is a teacher if it modifies its behaviour in the presence of a naïve observer, at some initial cost to itself, in order to set an example so that the other individual can learn more quickly.

Professor Franks said: "We also believe that true teaching always involves feedback in both directions between the teacher and the pupil. In other words, the teacher provides information or guidance for the pupil at a rate suited to the pupil's abilities, and the pupil signals to the teacher when parts of the 'lesson' have been assimilated and that the lesson may continue."

Tandem running in Temnothorax ants meets all these criteria and thus qualifies as teaching. At the start of a tandem run, the leader finds a naïve individual who is willing to follow her. But tandem runs are rather slow because the follower frequently pauses to look round for landmarks so that it can learn the route. Only when the follower has done this does it tap on the hind legs and abdomen of the leader to let it know that the tandem run can proceed.

The researchers' detailed analysis of the movements of tandem leaders and tandem followers shows the mutual feedback between them: if the gap between them gets too large, the leader decelerates and the follower accelerates, and if the gap
'"/>

Source:University of Bristol


Page: 1 2

Related biology news :

1. Timing is everything: First step in protein building revealed
2. Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
3. First atlas of key brain genes could speed research on cancer, neurological diseases
4. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
5. NYCs First Rapid HIV Drug-resistant AIDS Case Prompts Call to Step Up HIV Prevention
6. First real-time view of developing neurons reveals surprises, say Stanford researchers
7. Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth
8. Mayo Clinic Researchers Create Obedient Virus; First Step To Use Measles Virus Against Cancer
9. First frozen egg baby born in Canada
10. Human Cells Filmed Instantly Messaging for First Time
11. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
Post Your Comments:
Breaking Biology News(10 mins):Canna can: Ornamental eliminates pollutants from stormwater runoff 2New engineering institute to modify, develop technology for the global poor 2New engineering institute to modify, develop technology for the global poor 3Berkeley Lab researchers participate in Homeland Security study of subway airflow 2CIGNA Awarded State of Arizona Health Care Contract 54926 1CIGNA Awarded State of Arizona Health Care Contract 54926 2Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 1Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 2Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 3Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 4Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 5Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 6Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 7Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 8Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 9Newer Drug Beats Tamoxifen for Older Breast Cancer Patients 54919 1Newer Drug Beats Tamoxifen for Older Breast Cancer Patients 54919 2Newer Drug Beats Tamoxifen for Older Breast Cancer Patients 54919 3